RESEARCH ON CLINICAL AND PARACLINICAL CHARACTERISTICS OF CANDIDEMIA AT VIET TIEP FRIENDSHIP HOSPITAL
Main Article Content
Abstract
Background: Candidemia is a leading cause of invasive fungal infections in hospitals, particularly among critically ill patients, the elderly, and those with multiple comorbidities or immunosuppression. Objectives: This study aimed to describe the epidemiological, clinical, and laboratory characteristics of candidemia and analyze factors associated with treatment outcomes at Viet Tiep Friendship Hospital.
Methods: A retrospective cross‑sectional study was conducted on 34 patients with positive blood cultures for Candida spp between October 2024 and September 2025. Clinical data, laboratory findings, and microbiological results were extracted from medical records.
Results: The mean age was 65.3 ± 16.7 years; 73.5% were male. The most common comorbidities were: cardiovascular disease (52.9%), diabetes mellitus (50%), cerebrovascular disease (26.5%), chronic kidney disease (20.6%). The most clinical features: fever (85.3%), pneumonia (79.4%), septic shock (47.1%), respiratory failure (38.2%). Microbiology: Non‑albicans Candida predominated (70.6%), with C. tropicalis (26.5%) and C. parapsilosis (23.5%) most frequent. Clinical outcomes includes: recovery in 29.4%, deterioration in 23.5%, and mortality in 14.7%.
Conclusion: Candidemia at Viet Tiep Hospital is characterized by high morbidity in elderly ICU patients with significant comorbidities. Candidemia present with severe clinical manifestations, with mortality and deterioration rates exceeding one-third of patients (38.2%). And non – albicans Candida predominated (70.6%). Early recognition of risk factors, timely diagnosis, appropriate antifungal therapy, and strict infection control measures are essential to reduce complications and mortality.
Article Details
Keywords
candidemia, invasive candida infection, antifungal
References
[2] Atiencia-Carrera, M.B., F.S. Cabezas-Mera, E. Tejera, and A. Machado, Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis. PLoS One, 2022. 17(2): p. e0263522.
[3] Pappas, P.G., C.A. Kauffman, D.R. Andes, C.J. Clancy, K.A. Marr, L. Ostrosky-Zeichner, A.C. Reboli, M.G. Schuster, J.A. Vazquez, T.J. Walsh, T.E. Zaoutis, and J.D. Sobel, Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016. 62(4): p. e1-50.
[4] Liu, T., S. Sun, X. Zhu, H. Wu, Z. Sun, and S. Peng, Epidemiology, clinical characteristics, and outcome in candidemia: a retrospective five-year analysis from two tertiary general hospitals. BMC Infect Dis, 2025. 25(1): p. 512.
[5] Duong, T.N., M.H. Le, J. Beardsley, D.W. Denning, N.H. Le, and B.T. Nguyen, Updated estimation of the burden of fungal disease in Vietnam. Mycoses, 2023. 66(4): p. 346-353.
[6] Bộ Y tế, Hướng dẫn chẩn đoán và điều trị nhiễm nấm xâm lấn. Ban hành kèm theo quyết định số 3429/QĐ-BYT ngày 14/7/2021
[7] Phạm Hồng Thắm, Nguyễn Cấp Tăng, Trương Thị Hà, Nguyễn Tú Anh, Khảo sát tình hình nhiễm Candida máu tại Bệnh viện Nhân Dân Gia Định. TẠP CHÍ Y HỌC VIỆT NAM 2022. 520(SỐ CHUYÊN ĐỀ): p. 8.
[8] Phạm Văn Phúc, Lê Thị Huyền, Roãn Thị Hương, Lương Hương Giang, Đặc điểm dịch tễ học, lâm sàng và kết quả điều trị ở bệnh nhân nhiễm Cadida máu tại khoa Hồi sức tích cực, Bệnh viện Bệnh nhiệt đới Trung ương. Vietnam Medical Journal 2025. 3(FEBRUARY ): p. 5.
[9] Cabrera-Guerrero, J.P., E. García-Salazar, G. Hernandez Silva, A. Chinney Herrera, E. Martínez-Herrera, R. Pinto-Almazán, M.G. Frías-De-León, and C.A. Castro-Fuentes, Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment. Pathogens, 2025. 14(8).
[10] Nguyen Thi Linh Chi, N.T.A.V., Le Nguyen Minh Hoa, Nguyen Minh Toan, Nguyen Thu Huong, Prevalence and antifungal susceptibility of invasive Candida species among hospitalized patients: A cross-sectional study in Vietnam. Asian Journal of Medical Sciences, , 2025. 16(8): p. 6.